FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

19172211000001100: Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-Jun 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
64308301000001116 Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
64308401000001112 Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Is a Nalidixic acid 300mg/5ml oral suspension 150 ml true Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Has AMP Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Has excipient Sorbic acid false Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Has specific active ingredient Nalidixic acid true Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Nalidixic acid 300mg/5ml oral suspension (Rosemont Pharmaceuticals Ltd) 150 ml VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start